All Relations between Neuromyelitis Optica and oligodendrocyte

Publication Sentence Publish Date Extraction Date Species
Itay Lotan, Thibo Billiet, Annemie Ribbens, Wim Van Hecke, Benny Huang, Ilya Kister, Eyal Lota. Volumetric brain changes in MOGAD: A cross-sectional and longitudinal comparative analysis. Multiple sclerosis and related disorders. vol 69. 2022-12-13. PMID:36512956. relatively little is known about how global and regional brain volumes changes in myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) compare with multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), and healthy controls (hc). 2022-12-13 2023-08-14 Not clear
Hadas Stiebel-Kalish, Kerstin Rubarth, Karny Shouchane-Blum, Alon Tiosano, Itay Lotan, Mark A Hellmann, Adi Wilf-Yarkoni, Omer Bialer, Eoin P Flanagan, Sean J Pittock, M Tariq Bhatti, Tanja Schmitz-Hübsch, Paul Friedemann, Susanna Asseyer, John J Che. Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis. Scientific reports. vol 12. issue 1. 2022-12-09. PMID:36494385. optic neuritis (on) is a frequent presentation at onset of multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). 2022-12-09 2023-08-14 Not clear
Angelika Bauer, Dagmar Rudzki, Klaus Berek, Alessandro Dinoto, Christian Lechner, Eva-Maria Wendel, Harald Hegen, Florian Deisenhammer, Thomas Berger, Romana Höftberger, Kevin Rostasy, Sara Mariotto, Markus Reind. Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder. Frontiers in immunology. vol 13. 2022-12-01. PMID:36451827. increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder. 2022-12-01 2023-08-14 Not clear
Angelika Bauer, Dagmar Rudzki, Klaus Berek, Alessandro Dinoto, Christian Lechner, Eva-Maria Wendel, Harald Hegen, Florian Deisenhammer, Thomas Berger, Romana Höftberger, Kevin Rostasy, Sara Mariotto, Markus Reind. Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder. Frontiers in immunology. vol 13. 2022-12-01. PMID:36451827. autoantibody-associated demyelinating diseases of the central nervous system such as myelin oligodendrocyte glycoprotein-antibody associated disease (mogad) and aquaporin 4-antibody positive neuromyelitis optica spectrum disorders (aqp4+ nmosd) are rare diseases but can cause severe disability. 2022-12-01 2023-08-14 Not clear
Jamie Jacobs, Priscilla Vu, Antonio K Li. A Patient With Myelin Oligodendrocyte Glycoprotein Positive Encephalitis With Ring Enhancing Lesions on Magnetic Resonance Imaging (MRI) After COVID-19 Exposure. Cureus. vol 14. issue 11. 2022-11-30. PMID:36447808. myelin oligodendrocyte glycoprotein (mog) antibody has been associated with a wide range of neurological diseases, from neuromyelitis optica spectrum disorder to acute disseminated encephalomyelitis. 2022-11-30 2023-08-14 Not clear
Giulia Fadda, Eoin P Flanagan, Laura Cacciaguerra, Jiraporn Jitprapaikulsan, Paolo Solla, Pietro Zara, Elia Sech. Myelitis features and outcomes in CNS demyelinating disorders: Comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD. Frontiers in neurology. vol 13. 2022-11-24. PMID:36419536. three main demyelinating disorders of the central nervous system, namely multiple sclerosis (ms), aquaporin-4-igg-positive neuromyelitis optica spectrum disorders (aqp4+nmosd) and myelin oligodendrocyte glycoprotein-igg associated disease (mogad), can induce spinal cord inflammation through different pathogenic mechanisms, resulting in a more or less profound disruption of spinal cord integrity. 2022-11-24 2023-08-14 Not clear
Magdalena Lerch, Kathrin Schanda, Eliott Lafon, Reinhard Würzner, Sara Mariotto, Alessandro Dinoto, Eva Maria Wendel, Christian Lechner, Harald Hegen, Kevin Rostásy, Thomas Berger, Doris Wilflingseder, Romana Höftberger, Markus Reind. More Efficient Complement Activation by Anti-Aquaporin-4 Compared With Anti-Myelin Oligodendrocyte Glycoprotein Antibodies. Neurology(R) neuroimmunology & neuroinflammation. vol 10. issue 1. 2022-11-22. PMID:36414427. the objective was to study complement-mediated cytotoxicity induced by immunoglobulin g (igg) anti-aquaporin-4 antibodies (aqp4-igg) and anti-myelin oligodendrocyte glycoprotein antibodies (mog-igg) in human serum samples from patients suffering from the rare demyelinating diseases of the cns neuromyelitis optica spectrum disorder (nmosd) and mog-igg-associated disease (mogad). 2022-11-22 2023-08-14 human
Dimitrios C Ladakis, Jennifer Gould, Jenny M Khazen, Julia M Lefelar, Scott Tarpey, Charles J Bies, Rebecca Salky, Kathryn C Fitzgerald, Pavan Bhargava, Bardia Nourbakhsh, Elias S Sotircho. Fatigue is a common symptom in myelin oligodendrocyte glycoprotein antibody disease. Multiple sclerosis journal - experimental, translational and clinical. vol 8. issue 4. 2022-11-21. PMID:36407471. unlike multiple sclerosis and neuromyelitis optica, the burden of fatigue in myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) is unclear. 2022-11-21 2023-08-14 Not clear
Darius Mewes, Joseph Kuchling, Patrick Schindler, Ahmed Abdelrahim Ahmed Khalil, Sven Jarius, Friedemann Paul, Claudia Chie. Diagnosis of Neuromyelitis Optica Spectrum Disorder (NMOSD) and MOG Antibody-Associated Disease (MOGAD). Klinische Monatsblatter fur Augenheilkunde. vol 239. issue 11. 2022-11-21. PMID:36410333. aquaporin-4 antibody-seropositive neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad; also termed mog encephalomyelitis) are autoimmune diseases of the central nervous system. 2022-11-21 2023-08-14 Not clear
Anna G Francis, Kariem Elhadd, Valentina Camera, Monica Ferreira Dos Santos, Chiara Rocchi, Poneh Adib-Samii, Bal Athwal, Kathrine Attfield, Andrew Barritt, Matthew Craner, Leonora Fisniku, Astrid K N Iversen, Oliver Leach, Lucy Matthews, Ian Redmond, Jonathan O'Riordan, Antonio Scalfari, Radu Tanasescu, Damian Wren, Saif Huda, Maria Isabel Leite, Lars Fugger, Jacqueline Palac. Acute Inflammatory Diseases of the Central Nervous System After SARS-CoV-2 Vaccination. Neurology(R) neuroimmunology & neuroinflammation. vol 10. issue 1. 2022-11-21. PMID:36411077. acute inflammatory cns diseases include neuromyelitis optica spectrum disorders (nmosds) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). 2022-11-21 2023-08-14 Not clear
Abhay Ranjan, Sanaullah Mudassir, Neetu Sinha, Ankit Panjwani, Ashok Kuma. Area Postrema Syndrome: An Initial Presentation of Double-Seropositive AQP4 and MOG Antibodies. Neurology. Clinical practice. vol 12. issue 4. 2022-11-16. PMID:36382120. aps is mostly associated with neuromyelitis optica (nmo) and rarely reported in myelin oligodendrocyte glycoprotein antibody disease. 2022-11-16 2023-08-14 Not clear
Negar Molazadeh, Gauruv Bose, Itay Lotan, Michael Lev. Autoimmune diseases and cancers overlapping with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A systematic review. Multiple sclerosis journal - experimental, translational and clinical. vol 8. issue 4. 2022-10-31. PMID:36311694. myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) has various similarities with aqp4-igg-seropositive neuromyelitis optica spectrum disorder (aqp4-igg + nmosd) in terms of clinical presentations, magnetic resonance imaging (mri) findings, and response to treatment. 2022-10-31 2023-08-14 Not clear
Zina Alme. [OPTIC NEURITIS - CLASSIFICATION, MANAGEMENT AND TREATMENT]. Harefuah. vol 161. issue 10. 2022-10-31. PMID:36315205. the understanding and the classification of atypical optic neuritis evolved significantly since the discovery of the anti-aquaporin4 (aqp4) and the anti-myelin oligodendrocyte glycoprotein (mog) antibodies as biomarkers and pathologic causes of neuromyelitis optica spectrum disorder (nmosd) and mog-associated disorder (mogad) respectively. 2022-10-31 2023-08-14 Not clear
Gregorio Spagni, Bo Sun, Gabriele Monte, Elia Sechi, Raffaele Iorio, Amelia Evoli, Valentina Damat. Efficacy and safety of rituximab in myelin oligodendrocyte glycoprotein antibody-associated disorders compared with neuromyelitis optica spectrum disorder: a systematic review and meta-analysis. Journal of neurology, neurosurgery, and psychiatry. 2022-10-25. PMID:36283808. efficacy and safety of rituximab in myelin oligodendrocyte glycoprotein antibody-associated disorders compared with neuromyelitis optica spectrum disorder: a systematic review and meta-analysis. 2022-10-25 2023-08-14 Not clear
Gregorio Spagni, Bo Sun, Gabriele Monte, Elia Sechi, Raffaele Iorio, Amelia Evoli, Valentina Damat. Efficacy and safety of rituximab in myelin oligodendrocyte glycoprotein antibody-associated disorders compared with neuromyelitis optica spectrum disorder: a systematic review and meta-analysis. Journal of neurology, neurosurgery, and psychiatry. 2022-10-25. PMID:36283808. rituximab (rtx) efficacy in patients with myelin oligodendrocyte glycoprotein (mog) antibody-associated disorders (mogads) is still poorly understood, though it appears to be lower than in aquaporin-4-igg-positive neuromyelitis optica spectrum disorders (aqp4-igg+nmosds). 2022-10-25 2023-08-14 Not clear
Busayanut Puangsricharoen, Kavin Vanikieti, Panitha Jindahra, Tanyatuth Padungkiatsagu. Serum Vitamin D Levels and Status in Thai Optic Neuritis Subjects: A Case-Control Study. Clinical ophthalmology (Auckland, N.Z.). vol 16. 2022-10-17. PMID:36249444. to measure serum total vitamin d or 25-hydroxyvitamin d [25(oh)d] levels and status in immune-based optic neuritis (on) including neuromyelitis optica spectrum disorder (nmosd)-on, myelin oligodendrocyte glycoprotein antibody-associated disease (mogad)-on, autoimmune-on, and idiopathic-on and compare them with age- and sex-matched healthy controls. 2022-10-17 2023-08-14 human
Jonathan A Gernert, Rebecca Wicklein, Bernhard Hemmer, Tania Kümpfel, Benjamin Knier, Joachim Havl. Peripapillary hyper-reflective ovoid mass-like structures (PHOMS) in AQP4-IgG-positive neuromyelitis optica spectrum disease (NMOSD) and MOG-IgG-associated disease (MOGAD). Journal of neurology. 2022-10-16. PMID:36245037. currently, no data on the prevalence of phoms in other demyelinating diseases including aquaporine-4-igg-positive neuromyelitis optica spectrum disease (aqp4 + nmosd) or myelin oligodendrocyte glycoprotein-igg-associated disease (mogad) are reported. 2022-10-16 2023-08-14 Not clear
Paula Barreras, Eleni S Vasileiou, Angeliki G Filippatou, Kathryn C Fitzgerald, Michael Levy, Carlos A Pardo, Scott D Newsome, Ellen M Mowry, Peter A Calabresi, Elias S Sotircho. Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody Disease. Neurology. 2022-10-14. PMID:36240094. rituximab is used widely for relapse prevention in neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein (mog)-igg associated disease (mogad), however data regarding the effectiveness and safety of long-term rituximab use in these conditions are limited. 2022-10-14 2023-08-14 Not clear
Itay Lotan, Shuhei Nishiyama, Giovanna S Manzano, Melissa Lydston, Michael Lev. COVID-19 and the risk of CNS demyelinating diseases: A systematic review. Frontiers in neurology. vol 13. 2022-10-07. PMID:36203986. viral infections are a proposed possible cause of inflammatory central nervous system (cns) demyelinating diseases, including multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). 2022-10-07 2023-08-14 Not clear
Rosa Cortese, Ferran Prados Carrasco, Carmen Tur, Alessia Bianchi, Wallace Brownlee, Floriana De Angelis, Isabel De La Paz, Francesco Grussu, Lukas Haider, Anu Jacob, Baris Kanber, Lise Magnollay, Richard S Nicholas, Anand Trip, Marios Yiannakas, Ahmed T Toosy, Yael Hacohen, Frederik Barkhof, Olga Ciccarell. Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging. Neurology. 2022-10-03. PMID:36192175. relapsing remitting multiple sclerosis (rrms), aquaporin4 antibody-positive neuromyelitis optica spectrum disorder (aqp4-nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) may have overlapping clinical features. 2022-10-03 2023-08-14 Not clear